Cited by 10Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

What Can We Learn From Chinese Randomized Controlled Trials? A Systematic Review and Meta-Analysis of Chinese Venlafaxine Studies

Koesters, Markus, Zhang, Ying, Chun, Yong, Weinmann, Stefan, Becker, Thomas, Jin, Wei Dong·2011·Journal of Clinical Psychopharmacology

Abstract

This systematic review evaluated Chinese trials examining the efficacy of venlafaxine in the treatment of depression. Chinese databases CNKI and VIP and western databases were searched for blinded randomized controlled trial publications comparing venlafaxine to other antidepressants or placebo (in English or Chinese). Trials had to establish diagnosis of depression according to the Chinese Classification of Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, or International Classification of Diseases. Studies were excluded if more than 20% of participants had a primary diagnosis of dysthymia or if more than 15% had a primary diagnosis of bipolar disorder. Effect sizes were calculated as Hedges' g for rating scale scores and Mantel-Haenszel risk ratios (MH RR) for response and remission data. Effect sizes were combined in a fixed-effects model. A total of 25 studies were included. Nine trials compared venlafaxine to selective serotonin reuptake inhibitor; placebo-controlled trials were lacking. Quality was at best modest, and all trials were underpowered. There were more responders (MH RR, 1.08; 95% confidence interval [CI], 1.02-1.15) and remitters (MH RR, 1.12; 95% CI, 1.02-1.24) in venlafaxine groups compared with those in tricyclic antidepressant group. Hamilton Depression Rating Scale end point scores in the venlafaxine groups were lower (Hedges' g = 0.16; 95% CI, 0.04-0.27), and venlafaxine was better tolerated than tricyclic antidepressant (Hedges' g = 0.56; 95% CI, 0.37-0.74). There were no significant differences between venlafaxine and selective serotonin reuptake inhibitor on any of these parameters. Analyses of publication bias were inconclusive. Chinese researchers have published a number of randomized controlled trials comparing venlafaxine to active comparators, but study quality was found to be low. To make optimal use of their research potential Chinese, researchers will have to improve trial reporting and the peer-review process.

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e31820f932a

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

3 of the 32 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Koesters, M., Zhang, Y., Chun, Y., Weinmann, S., Becker, T., & Jin, W. D.
Affiliations
  • Universität Ulm (DE)
  • Tongde Hospital of Zhejiang Province (CN)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
  • Koesters, Markus
  • Zhang, Ying
  • Becker, Thomas
Venue
Journal of Clinical Psychopharmacology
Published
2011-04
Volume
31
Issue
2
Pages
194-200
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2031777299
Cited by
10
References
32
Citations by year
2026: 1 · 2024: 1 · 2018: 1 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
0.28
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
venlafaxine, depression, antidepressant efficacy, tricyclic antidepressants, selective serotonin reuptake inhibitors, trial quality, publication bias, drug tolerability, remission
MeSH terms
Venlafaxine Hydrochloride, Cyclohexanols, Depressive Disorder, Humans, Randomized Controlled Trials as Topic, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review